Factors Influencing Non-compliance with Anti-hypertensive Drug Therapy in Nigerians
Overview
Authors
Affiliations
Background: Non-compliance with antihypertensive drug therapy can have a negative impact on cardiovascular outcome. The objective of this study was to determine compliance rate with anti-hypertensive therapy and factors affecting compliance among patients attending a Nigerian tertiary hospital.
Methods: A cross sectional study was conducted on 225 black hypertensive patients attending a tertiary clinic in Lagos, Nigeria. Demographic data, current anti-hypertensive therapy, compliance with prescribed therapy, factors affecting compliance and BP were documented via an investigator administered questionnaire and open-ended interviews.
Results: In this study, 77(34.2%) of the hypertensive patients were non-compliant. Blood pressure control was significantly better among compliant patients (45.9%) than in non-compliant patients (27.3%) (x(2) = 7.35 p=0.007). Gender, age, number of drugs used, educational level and presence of co-morbidities did not affect compliance. The major reasons for non-compliance were miscellaneous factors (60%) related to both patient's attitudes and beliefs (reflecting ignorance),and consultation failure on the part of clinicians. Lack of finances and side effects of medications accounted for 23.8% and 16.2% of non-compliances respectively.
Conclusion: Although lack of finances is the single most self reported reason, miscellaneous factors related to patients' attitudes and belief contribute frequently. Incorporating patient education and counselling in routine follow-up may improve compliance, BP control, and ultimately impact positively on cardiovascular outcome.
African Stroke Organization Conference 2022: Stroke in the Age of Emerging Challenges and Advances.
Gebreyohanns M, Akinyemi R, Owolabi M, Sarfo F, Tagge R, Ovbiagele B J Am Heart Assoc. 2023; 12(24):e032647.
PMID: 38108250 PMC: 10863777. DOI: 10.1161/JAHA.123.032647.
Uncontrolled hypertension in a rural population of Jammu and Kashmir.
Arambam P, Khashoo R, Tewari D, Saleem Z, Shekhawat S, Kaul U Indian Heart J. 2022; 74(6):484-487.
PMID: 36460055 PMC: 9773274. DOI: 10.1016/j.ihj.2022.11.012.
Gebreyohanns M, Akinyemi R, Owolabi M, Sarfo F, Tagge R, Ovbiagele B J Stroke Cerebrovasc Dis. 2022; 31(4):106385.
PMID: 35317914 PMC: 9397143. DOI: 10.1016/j.jstrokecerebrovasdis.2022.106385.
Kumar A, Mohammadnezhad M, May W Patient Prefer Adherence. 2021; 15:1843-1852.
PMID: 34465983 PMC: 8403084. DOI: 10.2147/PPA.S322731.
Nkemdilim I, Ezeala-Adikaibe B, Donatus O, Innocent O, Ernest N, Nkeiruka M Ann Afr Med. 2021; 20(2):84-91.
PMID: 34213473 PMC: 8378469. DOI: 10.4103/aam.aam_20_20.